What is the treatment for Helicobacter pylori (H. pylori) infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for H. pylori Infection

The first-line treatment for H. pylori infection is a 14-day bismuth quadruple therapy consisting of a proton pump inhibitor (PPI) twice daily, bismuth 300mg four times daily, tetracycline 500mg four times daily, and metronidazole 500mg three times daily, which provides an eradication rate of approximately 85%. 1

First-Line Treatment Options

Standard Triple Therapy (for areas with low clarithromycin resistance)

  • PPI twice daily
  • Amoxicillin 1g twice daily
  • Clarithromycin 500mg twice daily
  • Duration: 14 days 1

Bismuth Quadruple Therapy (preferred when antibiotic susceptibility is unknown)

  • PPI twice daily
  • Bismuth 300mg four times daily
  • Tetracycline 500mg four times daily
  • Metronidazole 500mg three times daily
  • Duration: 14 days 1, 2

For Penicillin Allergy

  • Use bismuth quadruple therapy as described above 1

Treatment Duration and Efficacy

  • 14-day regimens are superior to 7-day regimens, providing approximately 5% better eradication rates 1
  • High-dose PPI increases the efficacy of triple therapy by 6-10% compared to standard doses 1
  • Standard PPI doses: omeprazole 20mg, lansoprazole 30mg, pantoprazole 40mg, esomeprazole 20mg, rabeprazole 20mg, dexlansoprazole 30mg 1

Alternative Regimens

  • Concomitant non-bismuth quadruple therapy (14 days): 80% eradication rate 1
  • For areas with high clarithromycin resistance (>15-20%), avoid clarithromycin-based regimens 1
  • Levofloxacin-based regimen for treatment failures: PPI twice daily, bismuth 300mg four times daily, levofloxacin 500mg once daily, and tetracycline 500mg four times daily for 14 days 1, 3

Post-Treatment Follow-up

  • Confirm eradication at least 4 weeks after completion of treatment 1
  • Use urea breath test (UBT) or laboratory-based validated monoclonal stool antigen test 1
  • Ensure patient has been off PPI for at least 2 weeks before testing 1
  • For uncomplicated duodenal ulcer, prolonged PPI therapy is not required after successful H. pylori eradication 1
  • For complicated duodenal ulcer, continue PPI until H. pylori eradication is confirmed 1

Special Considerations

  • For patients with renal impairment (GFR 10-30 mL/min), adjust amoxicillin dosing to 500mg or 250mg every 12 hours 1
  • For GFR <10 mL/min, adjust amoxicillin dosing to 500mg or 250mg every 24 hours 1
  • Patients with bleeding ulcers should start treatment when oral feeding is resumed 1

Patient Education

  • Inform patients about potential side effects:
    • Darkening of stool (from bismuth)
    • Metallic taste
    • Nausea and vomiting
    • Diarrhea
    • Skin rash
    • Muscle and joint pains 1
  • Emphasize the importance of completing the full course of treatment 1
  • Advise taking medications with meals to improve tolerance and efficacy 1

Common Pitfalls to Avoid

  1. Using shorter 7-day regimens instead of the more effective 14-day regimens
  2. Failing to confirm eradication after treatment
  3. Using clarithromycin-based regimens in areas with high resistance
  4. Not adjusting medication doses for patients with renal impairment
  5. Inadequate patient education about the importance of completing the full treatment course

The American College of Gastroenterology's 2024 guidelines strongly recommend bismuth quadruple therapy as the preferred regimen when antibiotic susceptibility is unknown, which is consistent with the American Gastroenterological Association's recommendations 1, 2.

References

Guideline

Gastritis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.

The American journal of gastroenterology, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.